2020
DOI: 10.1056/nejmc2009316
|View full text |Cite
|
Sign up to set email alerts
|

Universal Screening for SARS-CoV-2 in Women Admitted for Delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

59
946
20
57

Year Published

2020
2020
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 1,012 publications
(1,082 citation statements)
references
References 3 publications
59
946
20
57
Order By: Relevance
“…Recently published case series discuss clinical features and outcomes of pregnant women with suspected COVID-19. [1][2][3][4] In 1 series of 13 mothers with confirmed SARS-CoV-2 infection postpartum, 2 had a dry cough and 6 had ground-glass opacity infiltrates on chest CT. 1 In another retrospective single-centre study, 7 pregnant (third-trimester) women who tested positive for SARS-CoV-2 infection had infiltrates on CT consistent with infection but did not require intensive care postpartum. 2 Of a total of 20 reported patients, none developed postpartum acute decompensation.…”
Section: Discussionmentioning
confidence: 99%
“…Recently published case series discuss clinical features and outcomes of pregnant women with suspected COVID-19. [1][2][3][4] In 1 series of 13 mothers with confirmed SARS-CoV-2 infection postpartum, 2 had a dry cough and 6 had ground-glass opacity infiltrates on chest CT. 1 In another retrospective single-centre study, 7 pregnant (third-trimester) women who tested positive for SARS-CoV-2 infection had infiltrates on CT consistent with infection but did not require intensive care postpartum. 2 Of a total of 20 reported patients, none developed postpartum acute decompensation.…”
Section: Discussionmentioning
confidence: 99%
“…Our goal is to minimize its variance by strategically allocating finite samples in order to minimize the important posterior variances among the elements of θ. In plain language, some of the subpopulations are more important in shaping future disease dynamics than others, so MDI will preferentially allocate more samples to those subpopulations in a principled manner, 1 The next generation matrix N is non-negative and satisfies the conditions of the Perron-Frobenius theorem which means that it has a largest eigenvalue λ-for a next generation matrix, R 0 = λ-which is greater than or equal to all other eigenvalues, with a corresponding eigenvector x of non-negative components. This means that repeated applications of N to any initial vector that is not orthogonal to x will become increasingly parallel to x at a rate of λ/|λ 2 | per iteration, where λ 2 is the second largest eigenvalue of N .…”
Section: S22 Minimizing Posterior Uncertainty For Modelingmentioning
confidence: 99%
“…(S11) and modification as in Eq. (S12), the next generation matrix updates the vector of infected individuals per subpopulation ash t+1 = (I − D θ )N h t ≈ (I − D θ )kλx (S8)where x represents the eigenvector of N corresponding to the largest eigenvalue λ, and k is a constant k = x T h 1. There are two helpful interpretations of this equation.…”
mentioning
confidence: 99%
“…Recent evidence suggests asymptomatic prevalence may be as high as 15% in specific populations, potentially affecting strategies for screening and tracing in some regions. [5] Antibody testing is still not widely available, making it difficult to honestly assess the breadth of the pandemic and the potential for herd immunity. Vaccinations will also be a vital aspect of any future population-level interventions, although the timeline of their availability remains unclear.…”
mentioning
confidence: 99%